Robert T. Davis's Insider Trades & SAST Disclosures
Robert T. Davis's most recent trade in Integra Lifesciences Holdings Corp was a trade of 26,310 Non- Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on March 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert T. Davis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 26,310 | 26,310 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 12,425 | 75,561 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 907 | 63,136 (0%) | 0% | 24.0 | 21,723 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.95 per share. | 11 Mar 2025 | 472 | 64,043 (0%) | 0% | 23.9 | 11,304 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 10 Mar 2025 | 592 | 64,515 (0%) | 0% | 22.6 | 13,385 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 14,963 | 14,963 | - | - | Non- Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 13,805 | 67,131 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 6,478 | 53,326 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.22 per share. | 11 Mar 2024 | 1,952 | 46,848 (0%) | 0% | 36.2 | 70,701 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 1,581 | 65,107 (0%) | 0% | 35.9 | 56,726 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.22 per share. | 11 Mar 2024 | 458 | 48,800 (0%) | 0% | 36.2 | 16,589 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.88 per share. | 11 Mar 2024 | 443 | 66,688 (0%) | 0% | 35.9 | 15,895 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.73 per share. | 10 Mar 2024 | 635 | 49,258 (0%) | 0% | 36.7 | 23,324 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 8,736 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.59 per share. | 06 Mar 2024 | 8,736 | 58,241 (0%) | 0% | 32.6 | 284,663 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Sale of securities on an exchange or to another person at price $ 36.59 per share. | 06 Mar 2024 | 8,348 | 49,893 (0%) | 0% | 36.6 | 305,492 | Common Stock |
| Integra Lifesciences Holdi... | Robert Davis T. | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 3,721 | 49,505 (0%) | 0% | 0 | Common Stock | |
| Hallador Energy Co | Todd Robert Davis | FORMER CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.98 per share. | 22 Dec 2023 | 4,450 | 13,194 (0%) | 0% | 13.0 | 57,761 | Common Stock |
| Hallador Energy Co | Davis Robert Todd | SVP & CAO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Dec 2023 | 20,000 | 0 | - | - | Restricted Stock Units | |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.98 per share. | 01 Dec 2023 | 10,000 | 17,644 (0%) | 0% | 13.0 | 129,800 | Common Stock |
| Hallador Energy Co | Todd Davis Robert | SVP & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2023 | 10,000 | 20,000 | - | - | Restricted Stock Units | |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 10,000 | 30,000 | - | - | Restricted Stock Units | |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.22 per share. | 31 Jul 2023 | 10,000 | 12,252 (0%) | 0% | 9.2 | 92,200 | Common Stock |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.22 per share. | 31 Jul 2023 | 4,608 | 7,644 (0%) | 0% | 9.2 | 42,486 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 10,354 | 10,354 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 4,227 | 50,147 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 1,010 | 45,784 (0%) | 0% | 52.6 | 53,136 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 799 | 48,890 (0%) | 0% | 52.9 | 42,243 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 755 | 47,253 (0%) | 0% | 52.9 | 39,917 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.61 per share. | 10 Mar 2023 | 459 | 46,794 (0%) | 0% | 52.6 | 24,148 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 458 | 49,689 (0%) | 0% | 52.9 | 24,214 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 453 | 48,008 (0%) | 0% | 52.9 | 23,950 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.87 per share. | 10 Mar 2023 | 429 | 48,461 (0%) | 0% | 52.9 | 22,681 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.87 per share. | 01 Mar 2023 | 1,566 | 47,486 (0%) | 0% | 26.9 | 42,071 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Sale of securities on an exchange or to another person at price $ 55.21 per share. | 01 Mar 2023 | 1,566 | 45,920 (0%) | 0% | 55.2 | 86,463 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 1,566 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 2,379 | 41,191 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,883 | 45,920 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,779 | 44,037 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 1,067 | 42,258 (0%) | 0% | 0 | Common Stock | |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2023 | 20,000 | 40,000 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 9,193 | 9,193 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 4,608 | 43,386 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 3,269 | 38,778 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,109 | 42,000 (0%) | 0% | 65.1 | 72,207 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,080 | 38,812 (0%) | 0% | 65.1 | 70,319 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 811 | 39,892 (0%) | 0% | 65.1 | 52,804 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 665 | 41,335 (0%) | 0% | 65.1 | 43,298 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 335 | 41,000 (0%) | 0% | 65.1 | 21,812 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 297 | 40,703 (0%) | 0% | 65.1 | 19,338 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 277 | 43,109 (0%) | 0% | 65.1 | 18,035 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 6,466 | 35,509 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 3,936 | 29,043 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,956 | 25,107 (0%) | 0% | 0 | Common Stock | |
| Hallador Energy Co | Robert Todd Davis | SVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 10,000 | 20,000 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 9,232 | 9,232 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 3,063 | 22,857 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 288 | 22,361 (0%) | 0% | 68.1 | 19,613 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 210 | 22,151 (0%) | 0% | 68.1 | 14,301 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 208 | 22,649 (0%) | 0% | 68.1 | 14,165 | Common Stock |
| Integra Lifesciences Holdi... | Robert T. Davis | EVP & President, TT | Sale of securities on an exchange or to another person at price $ 69.48 per share. | 25 Feb 2021 | 24,941 | 19,794 (0%) | 0% | 69.5 | 1,732,963 | Common Stock |
| Hallador Energy Co | Robert Todd Davis | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2020 | 10,000 | 12,000 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges